View ValuationLevima Advanced Materials 将来の成長Future 基準チェック /06現在、 Levima Advanced Materialsの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長30.3%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報Price Target Changed • Mar 31Price target decreased by 13% to CN¥49.97Down from CN¥57.30, the current price target is an average from 3 analysts. New target price is 75% above last closing price of CN¥28.52. Stock is up 11% over the past year. The company is forecast to post earnings per share of CN¥0.94 for next year compared to CN¥0.82 last year.Price Target Changed • Apr 27Price target decreased to CN¥30.00Down from CN¥36.00, the current price target is an average from 3 analysts. New target price is 62% above last closing price of CN¥18.52. Stock is down 29% over the past year. The company is forecast to post earnings per share of CN¥0.91 for next year compared to CN¥0.82 last year.Major Estimate Revision • Mar 31Consensus EPS estimates fall by 22%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥9.47b to CN¥9.16b. EPS estimate also fell from CN¥1.25 per share to CN¥0.97 per share. Net income forecast to grow 24% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target down from CN¥70.00 to CN¥36.00. Share price fell 7.6% to CN¥25.68 over the past week.Major Estimate Revision • Apr 26Consensus EPS estimates increase to CN¥1.04The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from CN¥6.70b to CN¥6.82b. EPS estimate increased from CN¥0.93 to CN¥1.04 per share. Net income forecast to grow 73% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target up from CN¥36.00 to CN¥41.00. Share price rose 5.2% to CN¥33.50 over the past week.すべての更新を表示Recent updatesDeclared Dividend • Apr 26Dividend increased to CN¥0.07Dividend of CN¥0.07 is 17% higher than last year. Ex-date: 29th April 2026 Payment date: 29th April 2026 Dividend yield will be 0.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (24% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 56 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 73% to shift the payout ratio to a potentially unsustainable range, which is more than the 16% EPS decline seen over the last 5 years.お知らせ • Mar 31Levima Advanced Materials Corporation to Report Q1, 2026 Results on Apr 23, 2026Levima Advanced Materials Corporation announced that they will report Q1, 2026 results on Apr 23, 2026Reported Earnings • Mar 29Full year 2025 earnings released: EPS: CN¥0.23 (vs CN¥0.18 in FY 2024)Full year 2025 results: EPS: CN¥0.23 (up from CN¥0.18 in FY 2024). Revenue: CN¥6.34b (up 1.1% from FY 2024). Net income: CN¥305.7m (up 30% from FY 2024). Profit margin: 4.8% (up from 3.7% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.お知らせ • Mar 28Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing Chinaお知らせ • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2025 Results on Mar 28, 2026Levima Advanced Materials Corporation announced that they will report fiscal year 2025 results on Mar 28, 2026Reported Earnings • Oct 15Third quarter 2025 earnings released: EPS: CN¥0.05 (vs CN¥0.024 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.05 (up from CN¥0.024 in 3Q 2024). Revenue: CN¥1.66b (flat on 3Q 2024). Net income: CN¥71.7m (up 91% from 3Q 2024). Profit margin: 4.3% (up from 2.3% in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.New Risk • Oct 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (4.9% operating cash flow to total debt). Earnings have declined by 24% per year over the past 5 years. High level of non-cash earnings (21% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2025 Results on Oct 15, 2025Levima Advanced Materials Corporation announced that they will report Q3, 2025 results on Oct 15, 2025Reported Earnings • Aug 17Second quarter 2025 earnings released: EPS: CN¥0.071 (vs CN¥0.07 in 2Q 2024)Second quarter 2025 results: EPS: CN¥0.071. Revenue: CN¥1.37b (down 25% from 2Q 2024). Net income: CN¥89.3m (flat on 2Q 2024). Profit margin: 6.5% (up from 4.9% in 2Q 2024).お知らせ • Jul 02Levima Advanced Materials Corporation to Report First Half, 2025 Results on Aug 16, 2025Levima Advanced Materials Corporation announced that they will report first half, 2025 results on Aug 16, 2025Declared Dividend • Apr 24Dividend reduced to CN¥0.06Dividend of CN¥0.06 is 25% lower than last year. Ex-date: 29th April 2025 Payment date: 29th April 2025 Dividend yield will be 0.4%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (33% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 46 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 63% to shift the payout ratio to a potentially unsustainable range, which is more than the 18% EPS decline seen over the last 5 years.お知らせ • Apr 23Levima Advanced Materials Corporation Approves Cash Dividend on A Shares for the Year 2024, Payable on April 29, 2025Levima Advanced Materials Corporation at its Annual General Meeting held on 18 April 2025, approved the Cash dividend (tax included) on A shares of CNY 0.60000000 per 10 shares for the year 2024. Record date is 28 April 2025. Ex-date is 29 April 2025. Payment date is 29 April 2025.お知らせ • Mar 31Levima Advanced Materials Corporation to Report Q1, 2025 Results on Apr 26, 2025Levima Advanced Materials Corporation announced that they will report Q1, 2025 results on Apr 26, 2025New Risk • Mar 30New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.0% operating cash flow to total debt). Earnings have declined by 15% per year over the past 5 years. High level of non-cash earnings (22% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (3.7% net profit margin).Reported Earnings • Mar 30Full year 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.33 in FY 2023)Full year 2024 results: EPS: CN¥0.18 (down from CN¥0.33 in FY 2023). Revenue: CN¥6.27b (down 7.5% from FY 2023). Net income: CN¥234.4m (down 47% from FY 2023). Profit margin: 3.7% (down from 6.6% in FY 2023). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.お知らせ • Mar 29Levima Advanced Materials Corporation Proposes Final Cash Dividend for the Year 2024Levima Advanced Materials Corporation announced the profit distribution proposal for the year 2024 as final cash dividend (tax included) of CNY 0.60000000 per 10 shares.お知らせ • Mar 28Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China分析記事 • Feb 24Does Levima Advanced Materials (SZSE:003022) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...お知らせ • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2024 Results on Mar 28, 2025Levima Advanced Materials Corporation announced that they will report fiscal year 2024 results on Mar 28, 2025分析記事 • Dec 25Levima Advanced Materials Corporation's (SZSE:003022) Price Is Out Of Tune With RevenuesWith a median price-to-sales (or "P/S") ratio of close to 2.4x in the Chemicals industry in China, you could be...New Risk • Nov 14New major risk - Revenue and earnings growthEarnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). Earnings have declined by 13% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.2% net profit margin).分析記事 • Nov 02Earnings Troubles May Signal Larger Issues for Levima Advanced Materials (SZSE:003022) ShareholdersA lackluster earnings announcement from Levima Advanced Materials Corporation ( SZSE:003022 ) last week didn't sink the...Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.024 (vs CN¥0.059 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.024 (down from CN¥0.059 in 3Q 2023). Revenue: CN¥1.65b (down 4.4% from 3Q 2023). Net income: CN¥37.6m (down 52% from 3Q 2023). Profit margin: 2.3% (down from 4.5% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥14.65, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 72% over the past three years.お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2024 Results on Oct 26, 2024Levima Advanced Materials Corporation announced that they will report Q3, 2024 results on Oct 26, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥14.77, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 72% over the past three years.分析記事 • Sep 23Levima Advanced Materials Corporation's (SZSE:003022) Share Price Matching Investor OpinionLevima Advanced Materials Corporation's ( SZSE:003022 ) price-to-earnings (or "P/E") ratio of 64.2x might make it look...Board Change • Sep 03High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Na Sun was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: CN¥0.07 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.07 (down from CN¥0.13 in 2Q 2023). Revenue: CN¥1.83b (up 12% from 2Q 2023). Net income: CN¥89.3m (down 50% from 2Q 2023). Profit margin: 4.9% (down from 11% in 2Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 28% per year, which means it has not declined as severely as earnings.分析記事 • Jul 28Is Levima Advanced Materials (SZSE:003022) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...分析記事 • Jul 01Be Wary Of Levima Advanced Materials (SZSE:003022) And Its Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...お知らせ • Jun 29Levima Advanced Materials Corporation to Report First Half, 2024 Results on Jul 27, 2024Levima Advanced Materials Corporation announced that they will report first half, 2024 results on Jul 27, 2024分析記事 • Jun 09Why Investors Shouldn't Be Surprised By Levima Advanced Materials Corporation's (SZSE:003022) P/EWith a price-to-earnings (or "P/E") ratio of 58.4x Levima Advanced Materials Corporation ( SZSE:003022 ) may be sending...分析記事 • May 22At CN¥16.70, Is It Time To Put Levima Advanced Materials Corporation (SZSE:003022) On Your Watch List?While Levima Advanced Materials Corporation ( SZSE:003022 ) might not have the largest market cap around , it received...Reported Earnings • Apr 28First quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.11 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.04 (down from CN¥0.11 in 1Q 2023). Revenue: CN¥1.49b (down 5.6% from 1Q 2023). Net income: CN¥51.4m (down 65% from 1Q 2023). Profit margin: 3.5% (down from 9.3% in 1Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.Declared Dividend • Apr 20Dividend reduced to CN¥0.08Dividend of CN¥0.08 is 60% lower than last year. Ex-date: 25th April 2024 Payment date: 25th April 2024 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (24% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 36 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 85% over the next 3 years, which should provide support to the dividend and adequate earnings cover.分析記事 • Apr 04We Think That There Are More Issues For Levima Advanced Materials (SZSE:003022) Than Just Sluggish EarningsShareholders didn't appear too concerned by Levima Advanced Materials Corporation's ( SZSE:003022 ) weak earnings. Our...お知らせ • Mar 30Levima Advanced Materials Corporation to Report Q1, 2024 Results on Apr 27, 2024Levima Advanced Materials Corporation announced that they will report Q1, 2024 results on Apr 27, 2024Reported Earnings • Mar 29Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: CN¥0.33 (down from CN¥0.65 in FY 2022). Revenue: CN¥6.78b (down 17% from FY 2022). Net income: CN¥446.1m (down 49% from FY 2022). Profit margin: 6.6% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 31%. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 12% per year.分析記事 • Mar 28Levima Advanced Materials (SZSE:003022) May Have Issues Allocating Its CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...お知らせ • Mar 27Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China分析記事 • Mar 06After Leaping 33% Levima Advanced Materials Corporation (SZSE:003022) Shares Are Not Flying Under The RadarLevima Advanced Materials Corporation ( SZSE:003022 ) shareholders are no doubt pleased to see that the share price has...分析記事 • Feb 29Levima Advanced Materials (SZSE:003022) Seems To Be Using A Lot Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...New Risk • Feb 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). High level of non-cash earnings (28% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.6% average weekly change). Profit margins are more than 30% lower than last year (7.4% net profit margin).Valuation Update With 7 Day Price Move • Jan 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥14.36, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 39% over the past three years.お知らせ • Dec 30Levima Advanced Materials Corporation to Report Fiscal Year 2023 Results on Mar 27, 2024Levima Advanced Materials Corporation announced that they will report fiscal year 2023 results on Mar 27, 2024Reported Earnings • Oct 31Third quarter 2023 earnings released: EPS: CN¥0.059 (vs CN¥0.24 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.059 (down from CN¥0.24 in 3Q 2022). Revenue: CN¥1.73b (down 30% from 3Q 2022). Net income: CN¥78.4m (down 76% from 3Q 2022). Profit margin: 4.5% (down from 13% in 3Q 2022). Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.New Risk • Oct 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 7.4% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (30% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (7.4% net profit margin).お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2023 Results on Oct 26, 2023Levima Advanced Materials Corporation announced that they will report Q3, 2023 results on Oct 26, 2023New Risk • Jul 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 55% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.Price Target Changed • Mar 31Price target decreased by 13% to CN¥49.97Down from CN¥57.30, the current price target is an average from 3 analysts. New target price is 75% above last closing price of CN¥28.52. Stock is up 11% over the past year. The company is forecast to post earnings per share of CN¥0.94 for next year compared to CN¥0.82 last year.Buying Opportunity • Mar 15Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥38.71, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 20%. Revenue is forecast to grow by 49% in 2 years. Earnings is forecast to grow by 123% in the next 2 years.Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥35.24, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 8.0% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥38.84 per share.お知らせ • Dec 20Levima Advanced Materials Corporation announced that it expects to receive CNY 2.02 billion in fundingLevima Advanced Materials Corporation announced that it will enter into private placement of shares for the gross proceeds of CNY 2,020 million on December 19, 2022.Board Change • Nov 16High number of new and inexperienced directorsThere are 11 new directors who have joined the board in the last 3 years. The company's board is composed of: 11 new directors. No experienced directors. No highly experienced directors. Employee Representative Supervisor Jingjun Zhou is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Buying Opportunity • Nov 09Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 35%. The fair value is estimated to be CN¥47.01, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 20%. Revenue is forecast to grow by 43% in 2 years. Earnings is forecast to grow by 106% in the next 2 years.Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥38.55, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 14% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥47.07 per share.Buying Opportunity • Oct 13Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 2.4%. The fair value is estimated to be CN¥52.76, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 47% in 2 years. Earnings is forecast to grow by 104% in the next 2 years.Buying Opportunity • Sep 15Now 25% undervaluedOver the last 90 days, the stock is up 23%. The fair value is estimated to be CN¥57.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 48% in 2 years. Earnings is forecast to grow by 110% in the next 2 years.Buying Opportunity • Aug 31Now 28% undervaluedOver the last 90 days, the stock is up 54%. The fair value is estimated to be CN¥57.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 46% in 2 years. Earnings is forecast to grow by 83% in the next 2 years.Valuation Update With 7 Day Price Move • Aug 31Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to CN¥41.53, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 17x in the Chemicals industry in China. Total loss to shareholders of 19% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥57.70 per share.Valuation Update With 7 Day Price Move • Aug 01Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥47.70, the stock trades at a forward P/E ratio of 44x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 22% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥57.32 per share.Reported Earnings • Jul 28Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.21 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.26 (up from CN¥0.21 in 2Q 2021). Revenue: CN¥2.38b (up 18% from 2Q 2021). Net income: CN¥349.4m (up 29% from 2Q 2021). Profit margin: 15% (up from 13% in 2Q 2021). Over the next year, revenue is forecast to grow 22%, compared to a 42% growth forecast for the industry in China.Valuation Update With 7 Day Price Move • Jun 10Investor sentiment improved over the past weekAfter last week's 24% share price gain to CN¥33.45, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 28% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥53.49 per share.Valuation Update With 7 Day Price Move • May 20Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥25.47, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 3.3% over the past year.お知らせ • Apr 28Levima Advanced Materials Corporation Announces Cash Dividend for the Year 2021, Payable on May 6, 2022Levima Advanced Materials Corporation announced 2021 final profit distribution plan to be implemented (A shares) cash dividend/10 shares (tax included) is CNY 2.000000. Record date is May 5, 2022. Ex-date is May 6, 2022. The dividend will be payable on May 6, 2022.Price Target Changed • Apr 27Price target decreased to CN¥30.00Down from CN¥36.00, the current price target is an average from 3 analysts. New target price is 62% above last closing price of CN¥18.52. Stock is down 29% over the past year. The company is forecast to post earnings per share of CN¥0.91 for next year compared to CN¥0.82 last year.Board Change • Apr 27High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. No highly experienced directors. Non-Employee Supervisor Rongguang Liu is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Apr 22Levima Advanced Materials Corporation Approves Cash Dividend for 2021Levima Advanced Materials Corporation approved the profit distribution of CNY 2.00000000 per 10 shares (tax included) in its Annual General Meeting of 2021 held on 20 April 2022.Reported Earnings • Apr 06Full year 2021 earnings: EPS and revenues miss analyst expectationsFull year 2021 results: EPS: CN¥0.82 (up from CN¥0.56 in FY 2020). Revenue: CN¥7.58b (up 28% from FY 2020). Net income: CN¥1.09b (up 70% from FY 2020). Profit margin: 14% (up from 11% in FY 2020). Revenue missed analyst estimates by 5.6%. Earnings per share (EPS) also missed analyst estimates by 12%. Over the next year, revenue is forecast to grow 21%, compared to a 48% growth forecast for the industry in China.お知らせ • Apr 02Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2022Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2022, at 14:30 China Standard Time. Agenda: To consider 2021 work report of the board of directors; to consider 2021 work report of the supervisory committee; to consider 2021 annual report and its summary; to consider 2021 annual accounts; to consider 2021 profit distribution plan; to consider 2021 special report on the deposit and use of raised funds; and to consider reappointment of 2022 audit firm.お知らせ • Mar 31Levima Advanced Materials Corporation Proposes Cash DividendLevima Advanced Materials Corporation announced on 30 March 2022 the profit distribution proposal for 2021 as follows: Cash dividend/10 shares (tax included): CNY 2.00000000.Major Estimate Revision • Mar 31Consensus EPS estimates fall by 22%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥9.47b to CN¥9.16b. EPS estimate also fell from CN¥1.25 per share to CN¥0.97 per share. Net income forecast to grow 24% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target down from CN¥70.00 to CN¥36.00. Share price fell 7.6% to CN¥25.68 over the past week.Reported Earnings • Nov 03Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.17 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥1.84b (up 36% from 3Q 2020). Net income: CN¥280.8m (up 45% from 3Q 2020). Profit margin: 15% (up from 14% in 3Q 2020). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥53.72, the stock trades at a forward P/E ratio of 50x. Average forward P/E is 19x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥43.35 per share.お知らせ • Sep 29Levima Advanced Materials Corporation (SZSE:003022) entered into equity transfer agreement to acquire 8.14% stake in Jiangxi Keyuan Bio-Material Co., Ltd from Levima Group Co., Ltd. for CNY 28.5 million.Levima Advanced Materials Corporation (SZSE:003022) entered into equity transfer agreement to acquire 8.14% stake in Jiangxi Keyuan Bio-Material Co., Ltd from Levima Group Co., Ltd. for CNY 28.5 million on September 24, 2021. The consideration will be paid in cash. ShineWing acted as accountant to Legend Holdings Corporation.Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 26% share price decline to CN¥52.78, the stock trades at a forward P/E ratio of 49x. Average forward P/E is 20x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥43.73 per share.Reported Earnings • Aug 30Second quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.17 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥2.02b (up 50% from 2Q 2020). Net income: CN¥271.7m (up 41% from 2Q 2020). Profit margin: 13% (in line with 2Q 2020).Valuation Update With 7 Day Price Move • Aug 25Investor sentiment improved over the past weekAfter last week's 23% share price gain to CN¥46.38, the stock trades at a forward P/E ratio of 46x. Average forward P/E is 20x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥40.30 per share.Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improved over the past weekAfter last week's 31% share price gain to CN¥39.07, the stock trades at a forward P/E ratio of 42x. Average forward P/E is 19x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥40.33 per share.Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥32.91, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 19x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥37.54 per share.Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥26.43, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 19x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥36.92 per share.Major Estimate Revision • Apr 26Consensus EPS estimates increase to CN¥1.04The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from CN¥6.70b to CN¥6.82b. EPS estimate increased from CN¥0.93 to CN¥1.04 per share. Net income forecast to grow 73% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target up from CN¥36.00 to CN¥41.00. Share price rose 5.2% to CN¥33.50 over the past week.お知らせ • Feb 20+ 1 more updateLevima Advanced Materials Corporation (SZSE:003022) intends to acquire an additional 40% stake in Xinneng Phoenix (Tengzhou) Energy Co., Ltd. from ENN Natural Gas Co., Ltd. (SHSE:600803).Levima Advanced Materials Corporation (SZSE:003022) intends to acquire remaining 82.5% stake in Xinneng Phoenix (Tengzhou) Energy Co., Ltd. from ENN Natural Gas Co., Ltd. (SHSE:600803) and Langfang Huayuan Energy Technology Co., Ltd. on February 18, 2021. Under the terms, ENN Natural Gas Co., Ltd. (SHSE:600803) will transfer 40% stake and Langfang Huayuan Energy Technology Co., Ltd. transfer 42.5% stake in Xinneng Phoenix (Tengzhou) Energy Co., Ltd. The consideration will be paid in cash, which will be paid by the internal resources and/or bank loans of Levima Advanced Materials and does not involve its proceeds raised from the listing. Post completion, Levima Advanced Materials Corporation will hold 100% stake in Xinneng Phoenix (Tengzhou) Energy Co., Ltd. The consideration shall be determined by an audit institution and an asset evaluation institution with securities and futures-related business qualifications entrusted by Levima Advanced Materials Corporation shall conduct audit and evaluation on Xinneng Phoenix (Tengzhou) Energy Co., Ltd. on December 31, 2020. Both Levima Advanced Materials Corporation and ENN Natural Gas Co., Ltd. shall negotiate the final transaction price based on the evaluation report, and the final transaction price is subject to the formal equity transfer agreement. Xinneng Phoenix (Tengzhou) Energy Co., Ltd. reported net asset value of approximately CNY 1.7 billion and total assets of CNY 3.3 billion. The transaction is also subject to approved by the internal decision-making bodies of the parties (including but not limited to the board of directors and the general meetings/shareholders’ meeting). The Board of Directors of ENN Natural Gas Co., Ltd. has approved the transaction. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Levima Advanced Materials は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測SZSE:003022 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20267,044379-3,734777N/A12/31/20256,338306-3,679587N/A9/30/20255,869289-3,478439N/A6/30/20255,866254-2,958605N/A3/31/20256,320254-3,002598N/A12/31/20246,268234-2,762594N/A9/30/20246,808220-2,371934N/A6/30/20246,884261-2,915642N/A3/31/20246,689350-2,441804N/A12/31/20236,778446-2,240875N/A9/30/20236,676493-2,474533N/A6/30/20237,426735-1,2831,204N/A3/31/20238,177906-7681,218N/A1/1/20238,157866-4671,316N/A9/30/20228,3321,0462861,441N/A6/30/20227,6931,0064161,217N/A3/31/20227,3339286071,203N/A1/1/20227,5811,0918261,268N/A9/30/20217,6361,0401,0521,335N/A6/30/20217,1489521,0661,343N/A3/31/20216,5618121,0161,318N/A12/31/20205,9316417901,121N/A9/30/20205,501533574934N/A12/31/20195,674532N/A1,484N/A12/31/20185,795229N/A879N/A12/31/20174,65955N/A693N/A12/31/20164,017188N/A815N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 003022の予測収益成長が 貯蓄率 ( 2.4% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 003022の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 003022の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 003022の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 003022の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 003022の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 21:44終値2026/05/21 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Levima Advanced Materials Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。5 アナリスト機関Xiongwei JiaChina International Capital Corporation LimitedLin YangGuosen Securities Co., Ltd.Junjun ZhuHaitong International Research Limited2 その他のアナリストを表示
Price Target Changed • Mar 31Price target decreased by 13% to CN¥49.97Down from CN¥57.30, the current price target is an average from 3 analysts. New target price is 75% above last closing price of CN¥28.52. Stock is up 11% over the past year. The company is forecast to post earnings per share of CN¥0.94 for next year compared to CN¥0.82 last year.
Price Target Changed • Apr 27Price target decreased to CN¥30.00Down from CN¥36.00, the current price target is an average from 3 analysts. New target price is 62% above last closing price of CN¥18.52. Stock is down 29% over the past year. The company is forecast to post earnings per share of CN¥0.91 for next year compared to CN¥0.82 last year.
Major Estimate Revision • Mar 31Consensus EPS estimates fall by 22%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥9.47b to CN¥9.16b. EPS estimate also fell from CN¥1.25 per share to CN¥0.97 per share. Net income forecast to grow 24% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target down from CN¥70.00 to CN¥36.00. Share price fell 7.6% to CN¥25.68 over the past week.
Major Estimate Revision • Apr 26Consensus EPS estimates increase to CN¥1.04The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from CN¥6.70b to CN¥6.82b. EPS estimate increased from CN¥0.93 to CN¥1.04 per share. Net income forecast to grow 73% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target up from CN¥36.00 to CN¥41.00. Share price rose 5.2% to CN¥33.50 over the past week.
Declared Dividend • Apr 26Dividend increased to CN¥0.07Dividend of CN¥0.07 is 17% higher than last year. Ex-date: 29th April 2026 Payment date: 29th April 2026 Dividend yield will be 0.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (24% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 56 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 73% to shift the payout ratio to a potentially unsustainable range, which is more than the 16% EPS decline seen over the last 5 years.
お知らせ • Mar 31Levima Advanced Materials Corporation to Report Q1, 2026 Results on Apr 23, 2026Levima Advanced Materials Corporation announced that they will report Q1, 2026 results on Apr 23, 2026
Reported Earnings • Mar 29Full year 2025 earnings released: EPS: CN¥0.23 (vs CN¥0.18 in FY 2024)Full year 2025 results: EPS: CN¥0.23 (up from CN¥0.18 in FY 2024). Revenue: CN¥6.34b (up 1.1% from FY 2024). Net income: CN¥305.7m (up 30% from FY 2024). Profit margin: 4.8% (up from 3.7% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 28Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China
お知らせ • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2025 Results on Mar 28, 2026Levima Advanced Materials Corporation announced that they will report fiscal year 2025 results on Mar 28, 2026
Reported Earnings • Oct 15Third quarter 2025 earnings released: EPS: CN¥0.05 (vs CN¥0.024 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.05 (up from CN¥0.024 in 3Q 2024). Revenue: CN¥1.66b (flat on 3Q 2024). Net income: CN¥71.7m (up 91% from 3Q 2024). Profit margin: 4.3% (up from 2.3% in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
New Risk • Oct 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (4.9% operating cash flow to total debt). Earnings have declined by 24% per year over the past 5 years. High level of non-cash earnings (21% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).
お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2025 Results on Oct 15, 2025Levima Advanced Materials Corporation announced that they will report Q3, 2025 results on Oct 15, 2025
Reported Earnings • Aug 17Second quarter 2025 earnings released: EPS: CN¥0.071 (vs CN¥0.07 in 2Q 2024)Second quarter 2025 results: EPS: CN¥0.071. Revenue: CN¥1.37b (down 25% from 2Q 2024). Net income: CN¥89.3m (flat on 2Q 2024). Profit margin: 6.5% (up from 4.9% in 2Q 2024).
お知らせ • Jul 02Levima Advanced Materials Corporation to Report First Half, 2025 Results on Aug 16, 2025Levima Advanced Materials Corporation announced that they will report first half, 2025 results on Aug 16, 2025
Declared Dividend • Apr 24Dividend reduced to CN¥0.06Dividend of CN¥0.06 is 25% lower than last year. Ex-date: 29th April 2025 Payment date: 29th April 2025 Dividend yield will be 0.4%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (33% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 46 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 63% to shift the payout ratio to a potentially unsustainable range, which is more than the 18% EPS decline seen over the last 5 years.
お知らせ • Apr 23Levima Advanced Materials Corporation Approves Cash Dividend on A Shares for the Year 2024, Payable on April 29, 2025Levima Advanced Materials Corporation at its Annual General Meeting held on 18 April 2025, approved the Cash dividend (tax included) on A shares of CNY 0.60000000 per 10 shares for the year 2024. Record date is 28 April 2025. Ex-date is 29 April 2025. Payment date is 29 April 2025.
お知らせ • Mar 31Levima Advanced Materials Corporation to Report Q1, 2025 Results on Apr 26, 2025Levima Advanced Materials Corporation announced that they will report Q1, 2025 results on Apr 26, 2025
New Risk • Mar 30New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.0% operating cash flow to total debt). Earnings have declined by 15% per year over the past 5 years. High level of non-cash earnings (22% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (3.7% net profit margin).
Reported Earnings • Mar 30Full year 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.33 in FY 2023)Full year 2024 results: EPS: CN¥0.18 (down from CN¥0.33 in FY 2023). Revenue: CN¥6.27b (down 7.5% from FY 2023). Net income: CN¥234.4m (down 47% from FY 2023). Profit margin: 3.7% (down from 6.6% in FY 2023). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 29Levima Advanced Materials Corporation Proposes Final Cash Dividend for the Year 2024Levima Advanced Materials Corporation announced the profit distribution proposal for the year 2024 as final cash dividend (tax included) of CNY 0.60000000 per 10 shares.
お知らせ • Mar 28Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China
分析記事 • Feb 24Does Levima Advanced Materials (SZSE:003022) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
お知らせ • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2024 Results on Mar 28, 2025Levima Advanced Materials Corporation announced that they will report fiscal year 2024 results on Mar 28, 2025
分析記事 • Dec 25Levima Advanced Materials Corporation's (SZSE:003022) Price Is Out Of Tune With RevenuesWith a median price-to-sales (or "P/S") ratio of close to 2.4x in the Chemicals industry in China, you could be...
New Risk • Nov 14New major risk - Revenue and earnings growthEarnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). Earnings have declined by 13% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.2% net profit margin).
分析記事 • Nov 02Earnings Troubles May Signal Larger Issues for Levima Advanced Materials (SZSE:003022) ShareholdersA lackluster earnings announcement from Levima Advanced Materials Corporation ( SZSE:003022 ) last week didn't sink the...
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.024 (vs CN¥0.059 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.024 (down from CN¥0.059 in 3Q 2023). Revenue: CN¥1.65b (down 4.4% from 3Q 2023). Net income: CN¥37.6m (down 52% from 3Q 2023). Profit margin: 2.3% (down from 4.5% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥14.65, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 72% over the past three years.
お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2024 Results on Oct 26, 2024Levima Advanced Materials Corporation announced that they will report Q3, 2024 results on Oct 26, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥14.77, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 72% over the past three years.
分析記事 • Sep 23Levima Advanced Materials Corporation's (SZSE:003022) Share Price Matching Investor OpinionLevima Advanced Materials Corporation's ( SZSE:003022 ) price-to-earnings (or "P/E") ratio of 64.2x might make it look...
Board Change • Sep 03High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Na Sun was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: CN¥0.07 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.07 (down from CN¥0.13 in 2Q 2023). Revenue: CN¥1.83b (up 12% from 2Q 2023). Net income: CN¥89.3m (down 50% from 2Q 2023). Profit margin: 4.9% (down from 11% in 2Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 28% per year, which means it has not declined as severely as earnings.
分析記事 • Jul 28Is Levima Advanced Materials (SZSE:003022) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
分析記事 • Jul 01Be Wary Of Levima Advanced Materials (SZSE:003022) And Its Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...
お知らせ • Jun 29Levima Advanced Materials Corporation to Report First Half, 2024 Results on Jul 27, 2024Levima Advanced Materials Corporation announced that they will report first half, 2024 results on Jul 27, 2024
分析記事 • Jun 09Why Investors Shouldn't Be Surprised By Levima Advanced Materials Corporation's (SZSE:003022) P/EWith a price-to-earnings (or "P/E") ratio of 58.4x Levima Advanced Materials Corporation ( SZSE:003022 ) may be sending...
分析記事 • May 22At CN¥16.70, Is It Time To Put Levima Advanced Materials Corporation (SZSE:003022) On Your Watch List?While Levima Advanced Materials Corporation ( SZSE:003022 ) might not have the largest market cap around , it received...
Reported Earnings • Apr 28First quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.11 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.04 (down from CN¥0.11 in 1Q 2023). Revenue: CN¥1.49b (down 5.6% from 1Q 2023). Net income: CN¥51.4m (down 65% from 1Q 2023). Profit margin: 3.5% (down from 9.3% in 1Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.
Declared Dividend • Apr 20Dividend reduced to CN¥0.08Dividend of CN¥0.08 is 60% lower than last year. Ex-date: 25th April 2024 Payment date: 25th April 2024 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (24% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 36 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 85% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
分析記事 • Apr 04We Think That There Are More Issues For Levima Advanced Materials (SZSE:003022) Than Just Sluggish EarningsShareholders didn't appear too concerned by Levima Advanced Materials Corporation's ( SZSE:003022 ) weak earnings. Our...
お知らせ • Mar 30Levima Advanced Materials Corporation to Report Q1, 2024 Results on Apr 27, 2024Levima Advanced Materials Corporation announced that they will report Q1, 2024 results on Apr 27, 2024
Reported Earnings • Mar 29Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: CN¥0.33 (down from CN¥0.65 in FY 2022). Revenue: CN¥6.78b (down 17% from FY 2022). Net income: CN¥446.1m (down 49% from FY 2022). Profit margin: 6.6% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 31%. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 12% per year.
分析記事 • Mar 28Levima Advanced Materials (SZSE:003022) May Have Issues Allocating Its CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
お知らせ • Mar 27Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China
分析記事 • Mar 06After Leaping 33% Levima Advanced Materials Corporation (SZSE:003022) Shares Are Not Flying Under The RadarLevima Advanced Materials Corporation ( SZSE:003022 ) shareholders are no doubt pleased to see that the share price has...
分析記事 • Feb 29Levima Advanced Materials (SZSE:003022) Seems To Be Using A Lot Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
New Risk • Feb 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). High level of non-cash earnings (28% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.6% average weekly change). Profit margins are more than 30% lower than last year (7.4% net profit margin).
Valuation Update With 7 Day Price Move • Jan 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥14.36, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 39% over the past three years.
お知らせ • Dec 30Levima Advanced Materials Corporation to Report Fiscal Year 2023 Results on Mar 27, 2024Levima Advanced Materials Corporation announced that they will report fiscal year 2023 results on Mar 27, 2024
Reported Earnings • Oct 31Third quarter 2023 earnings released: EPS: CN¥0.059 (vs CN¥0.24 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.059 (down from CN¥0.24 in 3Q 2022). Revenue: CN¥1.73b (down 30% from 3Q 2022). Net income: CN¥78.4m (down 76% from 3Q 2022). Profit margin: 4.5% (down from 13% in 3Q 2022). Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.
New Risk • Oct 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 7.4% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (30% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (7.4% net profit margin).
お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2023 Results on Oct 26, 2023Levima Advanced Materials Corporation announced that they will report Q3, 2023 results on Oct 26, 2023
New Risk • Jul 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 55% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.
Price Target Changed • Mar 31Price target decreased by 13% to CN¥49.97Down from CN¥57.30, the current price target is an average from 3 analysts. New target price is 75% above last closing price of CN¥28.52. Stock is up 11% over the past year. The company is forecast to post earnings per share of CN¥0.94 for next year compared to CN¥0.82 last year.
Buying Opportunity • Mar 15Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥38.71, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 20%. Revenue is forecast to grow by 49% in 2 years. Earnings is forecast to grow by 123% in the next 2 years.
Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥35.24, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 8.0% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥38.84 per share.
お知らせ • Dec 20Levima Advanced Materials Corporation announced that it expects to receive CNY 2.02 billion in fundingLevima Advanced Materials Corporation announced that it will enter into private placement of shares for the gross proceeds of CNY 2,020 million on December 19, 2022.
Board Change • Nov 16High number of new and inexperienced directorsThere are 11 new directors who have joined the board in the last 3 years. The company's board is composed of: 11 new directors. No experienced directors. No highly experienced directors. Employee Representative Supervisor Jingjun Zhou is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Buying Opportunity • Nov 09Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 35%. The fair value is estimated to be CN¥47.01, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 20%. Revenue is forecast to grow by 43% in 2 years. Earnings is forecast to grow by 106% in the next 2 years.
Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥38.55, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 14% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥47.07 per share.
Buying Opportunity • Oct 13Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 2.4%. The fair value is estimated to be CN¥52.76, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 47% in 2 years. Earnings is forecast to grow by 104% in the next 2 years.
Buying Opportunity • Sep 15Now 25% undervaluedOver the last 90 days, the stock is up 23%. The fair value is estimated to be CN¥57.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 48% in 2 years. Earnings is forecast to grow by 110% in the next 2 years.
Buying Opportunity • Aug 31Now 28% undervaluedOver the last 90 days, the stock is up 54%. The fair value is estimated to be CN¥57.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 46% in 2 years. Earnings is forecast to grow by 83% in the next 2 years.
Valuation Update With 7 Day Price Move • Aug 31Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to CN¥41.53, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 17x in the Chemicals industry in China. Total loss to shareholders of 19% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥57.70 per share.
Valuation Update With 7 Day Price Move • Aug 01Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥47.70, the stock trades at a forward P/E ratio of 44x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 22% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥57.32 per share.
Reported Earnings • Jul 28Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.21 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.26 (up from CN¥0.21 in 2Q 2021). Revenue: CN¥2.38b (up 18% from 2Q 2021). Net income: CN¥349.4m (up 29% from 2Q 2021). Profit margin: 15% (up from 13% in 2Q 2021). Over the next year, revenue is forecast to grow 22%, compared to a 42% growth forecast for the industry in China.
Valuation Update With 7 Day Price Move • Jun 10Investor sentiment improved over the past weekAfter last week's 24% share price gain to CN¥33.45, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 28% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥53.49 per share.
Valuation Update With 7 Day Price Move • May 20Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥25.47, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 3.3% over the past year.
お知らせ • Apr 28Levima Advanced Materials Corporation Announces Cash Dividend for the Year 2021, Payable on May 6, 2022Levima Advanced Materials Corporation announced 2021 final profit distribution plan to be implemented (A shares) cash dividend/10 shares (tax included) is CNY 2.000000. Record date is May 5, 2022. Ex-date is May 6, 2022. The dividend will be payable on May 6, 2022.
Price Target Changed • Apr 27Price target decreased to CN¥30.00Down from CN¥36.00, the current price target is an average from 3 analysts. New target price is 62% above last closing price of CN¥18.52. Stock is down 29% over the past year. The company is forecast to post earnings per share of CN¥0.91 for next year compared to CN¥0.82 last year.
Board Change • Apr 27High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. No highly experienced directors. Non-Employee Supervisor Rongguang Liu is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Apr 22Levima Advanced Materials Corporation Approves Cash Dividend for 2021Levima Advanced Materials Corporation approved the profit distribution of CNY 2.00000000 per 10 shares (tax included) in its Annual General Meeting of 2021 held on 20 April 2022.
Reported Earnings • Apr 06Full year 2021 earnings: EPS and revenues miss analyst expectationsFull year 2021 results: EPS: CN¥0.82 (up from CN¥0.56 in FY 2020). Revenue: CN¥7.58b (up 28% from FY 2020). Net income: CN¥1.09b (up 70% from FY 2020). Profit margin: 14% (up from 11% in FY 2020). Revenue missed analyst estimates by 5.6%. Earnings per share (EPS) also missed analyst estimates by 12%. Over the next year, revenue is forecast to grow 21%, compared to a 48% growth forecast for the industry in China.
お知らせ • Apr 02Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2022Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2022, at 14:30 China Standard Time. Agenda: To consider 2021 work report of the board of directors; to consider 2021 work report of the supervisory committee; to consider 2021 annual report and its summary; to consider 2021 annual accounts; to consider 2021 profit distribution plan; to consider 2021 special report on the deposit and use of raised funds; and to consider reappointment of 2022 audit firm.
お知らせ • Mar 31Levima Advanced Materials Corporation Proposes Cash DividendLevima Advanced Materials Corporation announced on 30 March 2022 the profit distribution proposal for 2021 as follows: Cash dividend/10 shares (tax included): CNY 2.00000000.
Major Estimate Revision • Mar 31Consensus EPS estimates fall by 22%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥9.47b to CN¥9.16b. EPS estimate also fell from CN¥1.25 per share to CN¥0.97 per share. Net income forecast to grow 24% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target down from CN¥70.00 to CN¥36.00. Share price fell 7.6% to CN¥25.68 over the past week.
Reported Earnings • Nov 03Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.17 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥1.84b (up 36% from 3Q 2020). Net income: CN¥280.8m (up 45% from 3Q 2020). Profit margin: 15% (up from 14% in 3Q 2020). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥53.72, the stock trades at a forward P/E ratio of 50x. Average forward P/E is 19x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥43.35 per share.
お知らせ • Sep 29Levima Advanced Materials Corporation (SZSE:003022) entered into equity transfer agreement to acquire 8.14% stake in Jiangxi Keyuan Bio-Material Co., Ltd from Levima Group Co., Ltd. for CNY 28.5 million.Levima Advanced Materials Corporation (SZSE:003022) entered into equity transfer agreement to acquire 8.14% stake in Jiangxi Keyuan Bio-Material Co., Ltd from Levima Group Co., Ltd. for CNY 28.5 million on September 24, 2021. The consideration will be paid in cash. ShineWing acted as accountant to Legend Holdings Corporation.
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 26% share price decline to CN¥52.78, the stock trades at a forward P/E ratio of 49x. Average forward P/E is 20x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥43.73 per share.
Reported Earnings • Aug 30Second quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.17 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥2.02b (up 50% from 2Q 2020). Net income: CN¥271.7m (up 41% from 2Q 2020). Profit margin: 13% (in line with 2Q 2020).
Valuation Update With 7 Day Price Move • Aug 25Investor sentiment improved over the past weekAfter last week's 23% share price gain to CN¥46.38, the stock trades at a forward P/E ratio of 46x. Average forward P/E is 20x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥40.30 per share.
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improved over the past weekAfter last week's 31% share price gain to CN¥39.07, the stock trades at a forward P/E ratio of 42x. Average forward P/E is 19x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥40.33 per share.
Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥32.91, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 19x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥37.54 per share.
Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥26.43, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 19x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥36.92 per share.
Major Estimate Revision • Apr 26Consensus EPS estimates increase to CN¥1.04The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from CN¥6.70b to CN¥6.82b. EPS estimate increased from CN¥0.93 to CN¥1.04 per share. Net income forecast to grow 73% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target up from CN¥36.00 to CN¥41.00. Share price rose 5.2% to CN¥33.50 over the past week.
お知らせ • Feb 20+ 1 more updateLevima Advanced Materials Corporation (SZSE:003022) intends to acquire an additional 40% stake in Xinneng Phoenix (Tengzhou) Energy Co., Ltd. from ENN Natural Gas Co., Ltd. (SHSE:600803).Levima Advanced Materials Corporation (SZSE:003022) intends to acquire remaining 82.5% stake in Xinneng Phoenix (Tengzhou) Energy Co., Ltd. from ENN Natural Gas Co., Ltd. (SHSE:600803) and Langfang Huayuan Energy Technology Co., Ltd. on February 18, 2021. Under the terms, ENN Natural Gas Co., Ltd. (SHSE:600803) will transfer 40% stake and Langfang Huayuan Energy Technology Co., Ltd. transfer 42.5% stake in Xinneng Phoenix (Tengzhou) Energy Co., Ltd. The consideration will be paid in cash, which will be paid by the internal resources and/or bank loans of Levima Advanced Materials and does not involve its proceeds raised from the listing. Post completion, Levima Advanced Materials Corporation will hold 100% stake in Xinneng Phoenix (Tengzhou) Energy Co., Ltd. The consideration shall be determined by an audit institution and an asset evaluation institution with securities and futures-related business qualifications entrusted by Levima Advanced Materials Corporation shall conduct audit and evaluation on Xinneng Phoenix (Tengzhou) Energy Co., Ltd. on December 31, 2020. Both Levima Advanced Materials Corporation and ENN Natural Gas Co., Ltd. shall negotiate the final transaction price based on the evaluation report, and the final transaction price is subject to the formal equity transfer agreement. Xinneng Phoenix (Tengzhou) Energy Co., Ltd. reported net asset value of approximately CNY 1.7 billion and total assets of CNY 3.3 billion. The transaction is also subject to approved by the internal decision-making bodies of the parties (including but not limited to the board of directors and the general meetings/shareholders’ meeting). The Board of Directors of ENN Natural Gas Co., Ltd. has approved the transaction.